<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39448097</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-299X</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Primary care</Title><ISOAbbreviation>Prim Care</ISOAbbreviation></Journal><ArticleTitle>Adolescent Metabolic Screening.</ArticleTitle><Pagination><StartPage>603</StartPage><EndPage>611</EndPage><MedlinePgn>603-611</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pop.2024.05.011</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0095-4543(24)00051-4</ELocationID><Abstract><AbstractText>This article explores metabolic syndrome (MetS) in children and adolescents, shedding light on its significant influence on long-term cardiovascular health outcomes. We navigate the complex landscape of MetS, where there is no universally accepted definition, and explore its roots in factors like obesity and insulin resistance. We also discuss the challenges of diagnosing and understanding its relevance in pediatric populations. The article also discussed the impact of the COVID-19 pandemic on the metabolic well-being of adolescents. Also, we discuss the importance of addressing associated comorbidities and risk factors in the context of MetS.</AbstractText><CopyrightInformation>Copyright Â© 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sivakoti</LastName><ForeName>Kirti</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of General Pediatrics, University of Utah, 295 Chipeta Way, Suite 14, Salt Lake City, UT 84108, USA; Pediatric Autonomic and Unexplained Symptoms Evidence-Based (PAUSE) program, Primary Children's Center, Salt Lake City, Utah, USA. Electronic address: Kirti.sivakoti@hsc.utah.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Prim Care</MedlineTA><NlmUniqueID>0430463</NlmUniqueID><ISSNLinking>0095-4543</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024821" MajorTopicYN="Y">Metabolic Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="Y">Mass Screening</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007333" MajorTopicYN="N">Insulin Resistance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063766" MajorTopicYN="N">Pediatric Obesity</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adolescents</Keyword><Keyword MajorTopicYN="N">Dyslipidemia</Keyword><Keyword MajorTopicYN="N">Metabolic screening</Keyword><Keyword MajorTopicYN="N">Obesity</Keyword></KeywordList><CoiStatement>Disclosure The author has nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>20</Hour><Minute>56</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39448097</ArticleId><ArticleId IdType="doi">10.1016/j.pop.2024.05.011</ArticleId><ArticleId IdType="pii">S0095-4543(24)00051-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle>